← Back to Screener
JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares (ZJYL)
Price$2.08
Favorite Metrics
Price vs S&P 500 (26W)-85.05%
Price vs S&P 500 (4W)-13.80%
Market Capitalization$16.40M
P/E Ratio (Annual)13.77x
All Metrics
P/CF (Annual)5.65x
Book Value / Share (Quarterly)$3.79
P/TBV (Annual)3.10x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)2.53%
Cash Flow / Share (Quarterly)$-0.48
Price vs S&P 500 (YTD)-58.68%
Gross Margin (TTM)29.22%
Net Profit Margin (TTM)5.76%
EPS (TTM)$0.15
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$0.15
Revenue Growth (5Y)5.02%
EPS (Annual)$0.15
ROI (Annual)2.46%
Gross Margin (Annual)29.22%
Net Profit Margin (5Y Avg)12.54%
Cash / Share (Quarterly)$3.79
P/E Basic Excl Extra (TTM)13.77x
Revenue Growth QoQ (YoY)-16.53%
EPS Growth (5Y)61.62%
P/E Normalized (Annual)13.77x
ROA (Last FY)2.23%
Revenue Growth TTM (YoY)-11.98%
EBITD / Share (TTM)$0.13
ROE (5Y Avg)13.06%
Operating Margin (TTM)2.94%
Cash Flow / Share (Annual)$-0.48
P/B Ratio0.55x
P/B Ratio (Quarterly)2.98x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.34x
Net Interest Coverage (TTM)19.82x
ROA (TTM)2.34%
EPS Growth QoQ (YoY)-31.95%
EV / EBITDA (TTM)27.04x
EPS Incl Extra (Annual)$0.15
Current Ratio (Annual)1.86x
Quick Ratio (Quarterly)1.50x
3-Month Avg Trading Volume0.03M
52-Week Price Return-89.25%
P/E Incl Extra (TTM)13.77x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.65
P/S Ratio (Annual)0.79x
Asset Turnover (Annual)0.39x
52-Week High$19.70
Operating Margin (5Y Avg)11.33%
EPS Excl Extra (Annual)$0.15
CapEx CAGR (5Y)115.61%
26-Week Price Return-76.30%
Quick Ratio (Annual)1.50x
13-Week Price Return-39.39%
Total Debt / Equity (Annual)0.64x
Current Ratio (Quarterly)1.86x
Enterprise Value$27.777
Revenue / Share Growth (5Y)92.03%
Asset Turnover (TTM)0.41x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.90x
Pretax Margin (Annual)7.71%
Cash / Share (Annual)$3.79
3-Month Return Std Dev106.84%
Gross Margin (5Y Avg)33.36%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-18.22%
ROE (Last FY)4.02%
EPS Basic Excl Extra (Annual)$0.15
P/FCF (TTM)32.10x
Receivables Turnover (TTM)2.88x
Total Debt / Equity (Quarterly)0.64x
EPS Incl Extra (TTM)$0.15
Receivables Turnover (Annual)2.88x
ROI (TTM)2.59%
P/S Ratio (TTM)0.79x
Pretax Margin (5Y Avg)13.99%
Revenue / Share (Annual)$2.64
Tangible BV / Share (Annual)$3.65
Price vs S&P 500 (52W)-124.34%
P/E Ratio (TTM)13.77x
EPS Growth TTM (YoY)-39.58%
Year-to-Date Return-54.55%
5-Day Price Return-13.42%
EPS Normalized (Annual)$0.15
ROA (5Y Avg)8.79%
Net Profit Margin (Annual)5.76%
Month-to-Date Return-0.99%
EBITD / Share (Annual)$0.13
EPS Growth (3Y)108.05%
Operating Margin (Annual)2.94%
P/CF (TTM)5.65x
ROI (5Y Avg)11.68%
P/E Excl Extra (TTM)13.77x
EPS Basic Excl Extra (TTM)$0.15
P/TBV (Quarterly)3.10x
P/B Ratio (Annual)2.98x
Inventory Turnover (TTM)2.90x
Pretax Margin (TTM)7.71%
Book Value / Share (Annual)$3.79
Price vs S&P 500 (13W)-42.26%
Net Margin Growth (5Y)-15.81%
Beta7.31x
P/FCF (Annual)5.48x
Revenue / Share (TTM)$2.64
ROE (TTM)4.14%
52-Week Low$1.64
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares | 0.79x | 5.02% | 29.22% | 2.94% | $2.08 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
About
Jin Medical International designs, manufactures, and distributes rehabilitation equipment, with wheelchairs as its primary revenue-generating product. The company's portfolio also includes oxygen concentrators, respiratory aids, and assistive living devices, served through dealer networks across Japan, China, North America, and other international markets. Japan represents the company's largest geographic market, with significant presence in China and other developed economies.